Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19

An increase in the frequency of patients with arterial hypertension (AH) seeking medical care and its more severe course after a novel coronavirus infection (NCI), COVID-19, determines the need to study possible pathogenetic mechanisms of disease progression. Aim of the study was to investigate some...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Sevostyanova, Yu. A. Nikolaev, V. Ya. Polyakov, I. L. Emelyanova
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2024-11-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/1720
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849318769389731840
author E. V. Sevostyanova
Yu. A. Nikolaev
V. Ya. Polyakov
I. L. Emelyanova
author_facet E. V. Sevostyanova
Yu. A. Nikolaev
V. Ya. Polyakov
I. L. Emelyanova
author_sort E. V. Sevostyanova
collection DOAJ
description An increase in the frequency of patients with arterial hypertension (AH) seeking medical care and its more severe course after a novel coronavirus infection (NCI), COVID-19, determines the need to study possible pathogenetic mechanisms of disease progression. Aim of the study was to investigate some features of lipid metabolism and changes in hemostasis in patients with AH after NCI COVID-19. Material and methods. An analysis of the most informative indicators of lipid metabolism and hemostasis was carried out in 104 patients with AH underwent (more than 2 months ago) NCI, in comparison with 117 patients with AH, with no history of COVID-19. The study included men and women aged from 30 to 75 years. Determination of the concentration of lipids in blood serum was carried out using the photometric method on a biochemical analyzer AU 480 (Beckman Coulter, США). Hemostatic parameters were determined by the chromogenic method using an automatic hemostasis analyzer Technology Solution 190 (USA). Results and discussion. It was found that patients with AH underwent NCI had significantly higher serum levels of total cholesterol, LDL cho- lesterol, triglycerides, D-dimers, platelets and lower activated partial thromboplastin and thrombin time compared with patients without COVID-19. Conclusions. The data obtained indicate a tendency to atherogenic changes in the blood lipid profile and increased coagulation processes in patients with AH in the long-term period (more than 2 months) after suffering a NCI COVID-19.
format Article
id doaj-art-4715ac7efd684900a5a81eee3abd67e6
institution Kabale University
issn 2410-2512
2410-2520
language Russian
publishDate 2024-11-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj-art-4715ac7efd684900a5a81eee3abd67e62025-08-20T03:50:44ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202024-11-0144518118610.18699/SSMJ20240521696Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19E. V. Sevostyanova0Yu. A. Nikolaev1V. Ya. Polyakov2I. L. Emelyanova3Federal Research Center of Fundamental and Translational MedicineFederal Research Center of Fundamental and Translational MedicineFederal Research Center of Fundamental and Translational MedicineFederal Research Center of Fundamental and Translational MedicineAn increase in the frequency of patients with arterial hypertension (AH) seeking medical care and its more severe course after a novel coronavirus infection (NCI), COVID-19, determines the need to study possible pathogenetic mechanisms of disease progression. Aim of the study was to investigate some features of lipid metabolism and changes in hemostasis in patients with AH after NCI COVID-19. Material and methods. An analysis of the most informative indicators of lipid metabolism and hemostasis was carried out in 104 patients with AH underwent (more than 2 months ago) NCI, in comparison with 117 patients with AH, with no history of COVID-19. The study included men and women aged from 30 to 75 years. Determination of the concentration of lipids in blood serum was carried out using the photometric method on a biochemical analyzer AU 480 (Beckman Coulter, США). Hemostatic parameters were determined by the chromogenic method using an automatic hemostasis analyzer Technology Solution 190 (USA). Results and discussion. It was found that patients with AH underwent NCI had significantly higher serum levels of total cholesterol, LDL cho- lesterol, triglycerides, D-dimers, platelets and lower activated partial thromboplastin and thrombin time compared with patients without COVID-19. Conclusions. The data obtained indicate a tendency to atherogenic changes in the blood lipid profile and increased coagulation processes in patients with AH in the long-term period (more than 2 months) after suffering a NCI COVID-19.https://sibmed.elpub.ru/jour/article/view/1720covid-19lipid metabolismhemostasiscomorbidity
spellingShingle E. V. Sevostyanova
Yu. A. Nikolaev
V. Ya. Polyakov
I. L. Emelyanova
Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19
Сибирский научный медицинский журнал
covid-19
lipid metabolism
hemostasis
comorbidity
title Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19
title_full Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19
title_fullStr Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19
title_full_unstemmed Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19
title_short Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19
title_sort features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection covid 19
topic covid-19
lipid metabolism
hemostasis
comorbidity
url https://sibmed.elpub.ru/jour/article/view/1720
work_keys_str_mv AT evsevostyanova featuresoflipidmetabolismandhemostasisinpatientswitharterialhypertensionunderwentanewcoronavirusinfectioncovid19
AT yuanikolaev featuresoflipidmetabolismandhemostasisinpatientswitharterialhypertensionunderwentanewcoronavirusinfectioncovid19
AT vyapolyakov featuresoflipidmetabolismandhemostasisinpatientswitharterialhypertensionunderwentanewcoronavirusinfectioncovid19
AT ilemelyanova featuresoflipidmetabolismandhemostasisinpatientswitharterialhypertensionunderwentanewcoronavirusinfectioncovid19